Session Details: GLP-1 Receptor Agonist Use in Patients with Type 2 Diabetes After Acute Myocardial Infarction and PCI: A Retrospective Cohort Study Thursday, May 1, 2025;11:03-11:11 AM ET Walter E
The peptide carries a C20 fatty diacid moiety that extends its half-life, allowing once-weekly administration
In MetALD, the co-existence of metabolic risk factors (like obesity and T2DM) and moderate-to-high alcohol consumption creates a synergistic double-hit injury that accelerates disease progression and HCC risk significantly more than either factor alone
Warnings Tirzepatide carries a Boxed Warning for the risk of possible thyroid tumors
Other GLP-1 medications: Including Mounjaro, Wegovy, Ozempic, Saxenda, Victoza, Byetta, or Bydureon
A physician-led workflow designed for Florida patients who want transparent pricing and named pharmacy partners